Treatment with the drug tocilizumab has been shown to reduce the risk of death among hospitalized patients with severe COVID-19.
Tocilizumab cuts the risk of death by about 30%, according to a study published Tuesday.
The medication, which also goes by the name Actmera is primarily used to treat rheumatoid arthritis.
The medication is an immunosuppressive drug designed to reduce inflammation.
It also works to suppress interleukin 6, a type of protein involved in the inflammatory process in a number of diseases, including COVID-19.